Skip to main content

Sleep and Quality of Life in Endocrine Diseases

  • Chapter
Sleep and Quality of Life in Clinical Medicine

Summary

It is well established that a close relationship exists between sleep and hormones of the hypothalamic–pituitary axis. Sleep has an electrophysiological component and an endocrine component, i.e., the distinct patterns of hormone secretion. Both the electrophysiological and the hormonal component interact bi-directional. Sleep-endocrine rhythms are closely interrelated, and sleep is an important regulator of (neuro)endocrine function. The secretion of growth hormone (GH), prolactin (PRL), and thyrotropin (TSH) is markedly increased during sleep, whereas the secretion of adrenocorticotrophic hormone (ACTH) and cortisol is inhibited. Sleep deprivation is associated with decreased GH and PRL secretion, and increased cortisol and TSH secretion. The decrease of GH secretion, which occurs with advancing age, is strongly associated with impaired quality of sleep. Increasing age is associated with increased levels of cortisol, which is significant after age 50 years when sleep is more fragmented and REM sleep declines. GH deficiency in adults (AGHD) is a well-recognized clinical syndrome, which is characterized by abnormal body composition and most notably, impairment of quality of life (QoL). Recent studies on long-term treatment of adult GH-deficient patients have convincingly shown that GH replacement therapy improves QoL in association with a reduction in healthcare utilization. Chronic excess of glucocorticoids, Cushing’s syndrome, is associated with sleep disturbances, mood alterations, depression, and impaired QoL. Patients with thyroid disease have sleep disturbances and a significantly reduced health-related QoL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Steiger A, Holsboer F. Neuropeptides and human sleep. Sleep 1997;20:1038–1052.

    PubMed  CAS  Google Scholar 

  2. Van Cauter E, Plat L, Copinschi G. Interrelations between sleep and somatotropic axis. Sleep 1998;21:553–566.

    PubMed  Google Scholar 

  3. Krueger JM, Obal F Jr, Opp MR, Toth L, Johannsen L, Cady AB. Somnogenic cytokines and models concerning their effects on sleep. Yale J Biol Med 1990;63,157–172.

    PubMed  CAS  Google Scholar 

  4. Iranmanesch A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determents of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991;73:1081–1088.

    Google Scholar 

  5. Veldhuis JD. A tripeptidyl ensemble perspective of interactive control of growth hormone secretion. Horm Res 2003;60:86–101.

    Article  PubMed  CAS  Google Scholar 

  6. Guan X-M, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJS, et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 1997; 48:23–29.

    Article  PubMed  CAS  Google Scholar 

  7. Copinschi G, Leproult R, van Onderbergen A, Caufriez A, Cole KY, Schilling LM, et al. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology 1997;66:278–286.

    PubMed  CAS  Google Scholar 

  8. Van Cauter E, Copinschi G. Interactions between growth hormone secretion and sleep. In: Smith RG, Thorner MO, eds. Human Growth Hormone: Research and Clinical Practice. New Jersey; Humana Press, 2000:261–283.

    Chapter  Google Scholar 

  9. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51–58.

    PubMed  CAS  Google Scholar 

  10. Honda Y, Takahashi K, Takahashi S, Azumi K, Irie M, Skuma M, Tsusima T, Shizume K. Growth hormone secretion during noctural sleep in normal subjects. J Clin Endocrinol Metab 1969;29:20–29.

    PubMed  CAS  Google Scholar 

  11. Weibel L, Spiegel K, Gronfier C, Follenius M, Brandenberger G. Twenty-four-hour melatonin and core body temperature rhythms: their adaptation in night workers. Am J Physiol 1997;272:R948–R954.

    Google Scholar 

  12. Van Cauter E, Blackman JD, Roland D, Spire JP, Refetoff S, Polonski KS. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest 1991;88:934–942.

    PubMed  Google Scholar 

  13. Weitzman ED, Nogeire C, Perlow M, Sassin JF, Fukushima D, McGregor P, Gallagher TF, Hellman L. Effects of a prolonged 3-hour sleep-wake cycle on sleep stages, plasma cortisol, growth hormone and body temperature in man. J Clin Endocrinol Metab 1974;38:1018–1030.

    PubMed  CAS  Google Scholar 

  14. Weitzman E, Czeisler C, Zimmerman J, Ronda J. The sleep-wake pattern of cortisol and growth hormone secretion during non-entrained (free-running) conditions in man. In: Van Cauter E, Copinschi G, eds. Human Pituitary Hormones: Circadian and Episodic Variations. Martinus Nijhoff, The Hague, 1981;29–41.

    Google Scholar 

  15. Krueger J, Obal FJ. Growth hormone-releasing hormone and interleukin-1 in sleep regulation. FASEB J 1993;7:645–652.

    PubMed  CAS  Google Scholar 

  16. Van Cauter E, Plat L, Scharf M, Leproult R, Cespedes S, L’Hermite-Baleriaux M, Copinschi G. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Invest 1997;100:745–753.

    PubMed  Google Scholar 

  17. Prinz PN, Vitiello MV, Raskind MA, Thorpy MJ. Geriatrics: sleep disorders and aging. N Engl J Med 1990;323:520–526.

    Article  PubMed  CAS  Google Scholar 

  18. Copinschi G, Van Cauter E. Effect of ageing on modulation of hormonal secretions by sleep and circadian rhythmicity. Horm Res 1995;43:20–24.

    PubMed  CAS  Google Scholar 

  19. Tsai J, Zorilla L, Jacob K, Rosenberg S, Marcus D. Nocturnal monitoring of growth hormone, insulin, c-peptide, and glucose in patients with acromegaly. Am J Med Sci 1996;311:281–285.

    Article  PubMed  CAS  Google Scholar 

  20. Aström C. Interaction between sleep and growth hormone evaluated by manual polysomnography and automatic power spectral analysis. Acta Neurol Scand 1995;92:281–296.

    Article  PubMed  Google Scholar 

  21. Wu RH, Thorpy MJ. Effect of growth hormone treatment on sleep EEGs in growth hormone-deficient children. Sleep 1988;11:425–429.

    PubMed  CAS  Google Scholar 

  22. Hayashi M, Shimohira M, Saisho S, Shimozawa K, Iwakawa, Y. Sleep disturbance in children with growth hormone deficiency. Brain Dev 1992;14:170–174.

    PubMed  CAS  Google Scholar 

  23. Schneider HJ, Pagotto U, Stalla GK. Central effects of the somatotropic system. Eur J Endocrinol 2003;149:377–392.

    Article  PubMed  CAS  Google Scholar 

  24. Gilchrist FJ, Murray RD, Shalet SM. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. Clin Endocrinol (Oxf) 2002;57:363–370.

    Article  CAS  Google Scholar 

  25. Koltowska-Häggström M, Mattsson AF, Monson JP, Kind P, Badia X, Casanueva FF, Busschbach J, Koppeschaar HPF, Johannsson G. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life. Eur J Endocrinol 2006;155;1:109–119.

    Article  CAS  Google Scholar 

  26. Saller B, Mattson AF, Kahn PH, Koppeschaar HPF, Svensson J, Pompen M, Koltowska-Häggström M. Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults – comparison between Sweden, The Netherlands and Germany. Eur J Endocrinol 2006;154;6:843–850.

    Article  CAS  Google Scholar 

  27. Cordido F, Penalva A, Peino R, Casanueva FF, Dieguez C. Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects. Metabolism 1995;44:745–748.

    Article  PubMed  CAS  Google Scholar 

  28. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991;72:51–59.

    PubMed  CAS  Google Scholar 

  29. Cordido F, Casanueva FF, Vidal JI, Dieguez C. Study of insulin like growth factor I in human obesity. Horm Res 1991;36:187–191.

    Article  PubMed  CAS  Google Scholar 

  30. Cooper BG, White JES, Ashworth LA, Alberti KGMM, Gibson GJ. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 1995;18:172–179.

    PubMed  CAS  Google Scholar 

  31. Van Cauter E, Polonsky KS, Blackman JD, Roland D, Sturis J, Byrne MM, Scheen AJ. Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone and circadian cortisol rhythmicity. J Clin Endocrinol Metab 1994;79:1797–1805.

    Article  PubMed  Google Scholar 

  32. Saini J, Krieger J, Brandenberger G, Wittersheim G, Simon C, Follenuis M. Continuous positive airway pressure treatment: Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 1993;25:375–381.

    PubMed  CAS  Google Scholar 

  33. Goldstein SJ, Wu RHK, Thorpy MJ, Shprintzen RJ, Marion RE, Saenger P. Reversibility of deficient sleep entrained growth hormone secretion in a boy with achondroplasia and obstructive sleep apnea. Acta Endocrinol 1987;166:95–101.

    Google Scholar 

  34. Diorio D, Viau V, Meaney MJ. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 1993;13(9):3839–3847.

    PubMed  CAS  Google Scholar 

  35. Van Cauter E, Copinski G, Turek FW. Endocrine and other biologic rhythms. In: De Groot LJ, Jameson JL, De Groot LJ, et al., eds. Endocrinology. Philadelphia: WB Saunders, 2001;235–256.

    Google Scholar 

  36. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 2003;24(3):151–180.

    Article  PubMed  CAS  Google Scholar 

  37. Segall LA, Perrin JS, Walker CD, Stewart J, Amir S. Glucocorticoid rhythms control the rhythm of expression of the clock protein, Period2, in oval nucleus of the bed nucleus of the stria terminalis and central nucleus of the amygdala in rats. Neuroscience 2006;7;140(3):753–757.

    Article  CAS  Google Scholar 

  38. Vgontzas AN, Mastorakos G, Bixler EO, Kales A, Gold PW, Chrousos GP. Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications. Clin Endocrinol (Oxf) 1999;51(2):205–215.

    Article  CAS  Google Scholar 

  39. Backhaus J, Junghanns K, Hohagen F. Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Psychoneuroendocrinology 2004;29(9):1184–1191.

    Article  PubMed  CAS  Google Scholar 

  40. Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 2000;284:861–868.

    Article  PubMed  Google Scholar 

  41. Bourdeau I, Bard C, Noel B, Leclerc I, Cordeau MP, Belair M, Lesage J, Lafontaine L, Lacroix A. Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002;87(5):1949–1954.

    Article  PubMed  CAS  Google Scholar 

  42. Zanardi VA, Magna LA, Costallat LT. Cerebral atrophy related to corticotherapy in systemic lupus erythematosus (SLE). Clin Rheumatol 2001;20(4):245–250.

    Article  PubMed  CAS  Google Scholar 

  43. Schutter DJLG, Van Honk J, Koppeschaar HPF, Kahn RS. Cortisol and reduced interhemispheric coupling between the left prefrontal and the right parietal cortex. J Neuropsychiatry Clin Neurosci 2002;14:89–90.

    PubMed  Google Scholar 

  44. Schutter DJLG, Honk EJ van, Haan EHF de, Huffelen AC van, Koppeschaar HPF. Cortisol, depression and reduced cortico-cortical cross-talk in Cushing’s syndrome. J Endocrinol Invest 2004;27:683–686.

    PubMed  CAS  Google Scholar 

  45. Nieman LK, Chrousos GP, Kellner C, Spitz IM, Nisula BC, Cutler GB, et al. Successful treatment of Cushing’s syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 1985;61,536–540.

    Article  PubMed  CAS  Google Scholar 

  46. Van der Lely AJ, Foeken K, Van der Mast RC, Lamberts SWJ. Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann Int Med 1991;114:143–144.

    PubMed  Google Scholar 

  47. Scanlon MF, Toft AD. Regulation of thyrotropin secretion. In: Braverman LE and Utiger RD, eds. Werner & Ingbar’s The thyroid. A Fundamental and Clinical Text . Philadelphia, PA: Lippincott Williams & Wilkins, 2000;234–253.

    Google Scholar 

  48. Baumgartner A, Dietzel M, Saletu B, Wolf R, Campos-Barros A, Graf KJ, Kurten I, Mannsmann U. Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and estradiol in healthy young women. Psychiatry Res 1993;48(2):153–178.

    Article  PubMed  CAS  Google Scholar 

  49. Kuhs H, Farber D, Tolle R. Serum prolactin, growth hormone, total corticoids, thyroid hormones and thyrotropine during serial therapeutic sleep deprivation. Biol Psychiatry 1996;15;39(10):857–864.

    Article  CAS  Google Scholar 

  50. Bianchi GP, Zaccheroni V, Solaroli E, Vescini F, Cerutti R, Zoli M, Marchesini G. Health-related quality of life in patients with thyroid disorders. Qual Life Res 2004;13(1):45–54.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

Koppeschaar, H.P.F., Quik, E.H. (2008). Sleep and Quality of Life in Endocrine Diseases. In: Verster, J.C., Pandi-Perumal, S.R., Streiner, D.L. (eds) Sleep and Quality of Life in Clinical Medicine. Humana Press. https://doi.org/10.1007/978-1-60327-343-5_47

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-343-5_47

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-340-4

  • Online ISBN: 978-1-60327-343-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics